These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2581437)

  • 1. A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen.
    Bitran JD; Goldman M
    Am J Clin Oncol; 1985 Feb; 8(1):61-4. PubMed ID: 2581437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-platinum-containing combination chemotherapy for stage III-IV head and neck squamous carcinoma.
    Veronesi A; Magri MD; Tirelli U; Galligioni E; Frustaci S; Crivellari D; Tumolo S; Grigoletto E
    Tumori; 1983 Aug; 69(4):323-6. PubMed ID: 6194600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.
    Wittes RE; Spiro RH; Shah J; Gerold FP; Koven B; Strong EW
    Med Pediatr Oncol; 1977; 3(3):301-9. PubMed ID: 85249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J
    J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy in advanced squamous cell carcinoma of the ORL region].
    Lehnert M; Jakse R; Seewann HL
    Onkologie; 1984 Oct; 7(5):297-9. PubMed ID: 6083516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
    Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experience.
    Pannuti F; Guaraldi M; Martoni A; Melotti B; Morritti MG
    Ann Oncol; 1993; 4 Suppl 2():45-8. PubMed ID: 7688983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer.
    Chang PM; Teng HW; Chen PM; Chang SY; Chu PY; Tsai TL; Tai SK; Wang YF; Huang JL; Yang MH
    J Chin Med Assoc; 2008 Jul; 71(7):336-41. PubMed ID: 18653395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
    Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
    Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating cisplatinum and VAC ineffective in end stage squamous cell carcinoma of the head and neck.
    Siodlak MZ; Stell PM; Wilson JA; Green JA; Allison RS; Adler D; Squadrelli-Saraceno M
    J Laryngol Otol; 1990 Aug; 104(8):631-3. PubMed ID: 2230560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
    Paccagnella A; Pappagallo GL; Segati R; Zorat P; Cavaniglia G; Lunghi F; Migliorini V; Frattina A; Bianco A; Sileni VC
    Eur J Cancer; 1993; 29A(5):704-8. PubMed ID: 7682427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.